Answers are grounded in this paper and cite their sources.
Inflammatory anaemia improves in patients with RA treated with tocilizumab. This improvement correlates with the degree of suppression of systemic inflammation, reduction in hepcidin and haptoglobin and increase in iron-binding capacity. These clinical data provide evidence of a role for IL-6 signalling in the inflammatory anaemia of RA.
No takes yet. Share an insight, caveat, or question.
Isaacs et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: